About
Galil Medical develops cryotherapy solutions that address patient conditions across multiple physician specialties. Its treatment areas include conditions affecting the kidneys, liver, lungs, prostate, and bones, as well as targeted pain and nerve applications. The companys technology is designed to ablate diseased tissue through freezing using a technique known as cryotherapy. The core technology is based on the Joule-Thomson effect, in which compressed gas causes significant, rapid temperature changes. Galil Medical cryotherapy systems use compressed argon gas to produce extremely low temperatures. As the gas passes through the cryoablation needle, the tip of the needle is cooled, forming an ice ball that engulfs the tumor and destroys the tissue. A variety of needle types are available to sculpt a freeze zone for the tumors specific size and shape. Galil Medical was bought by BTG plc in May 2016.
Funding history · 1 round · $52.0M total
Company Intelligence Q&A
Structured intelligence from startupim data — optimized for AI retrieval and grounding.
- What is Galil Medical's primary focus?
- Galil Medical develops cryotherapy solutions for treating patient conditions across various physician specialties, including conditions affecting the kidneys, liver, lungs, prostate, and bones, as well as targeted pain and nerve applications.
- When was Galil Medical founded?
- Galil Medical was founded in January 1997.
- What is the core technology behind Galil Medical's cryotherapy systems?
- Galil Medical's core technology is based on the Joule-Thomson effect, utilizing compressed argon gas to produce extremely low temperatures for cryoablation, forming an ice ball to destroy diseased tissue.
- Where is Galil Medical's headquarters located?
- Galil Medical's headquarters is located in Yokne'am Illit, Israel.
- When and by whom was Galil Medical acquired?
- Galil Medical was acquired by BTG plc in May 2016 for $110 million.
- What was the total amount of funding raised by Galil Medical?
- Galil Medical raised a total of $52,000,000 in funding.
- Which investors participated in Galil Medical's last funding round?
- Galil Medical's last funding round in December 2006 included investors such as Investor Growth Capital, The Vertical Group, and Thomas, McNerney & Partners.
- What is the current status of Galil Medical?
- Galil Medical is currently inactive, having closed due to its acquisition by BTG plc in May 2016.